Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Taysha Gene Therapies, Inc. (TSHA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 186,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Taysha Gene Therapies is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. Co. owns the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, known as TSHA-120, for the treatment of giant axonal neuropathy (GAN). GAN is a rare autosomal recessive disease of the central and peripheral nervous systems caused by loss-of-function gigaxonin gene mutations. TSHA-120 is an AAV9 self-complementary viral vector encoding the full length human gigaxonin protein.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 100,000 17,905,000 19,405,000
Total Buy Value $0 $163,000 $16,186,400 $19,186,400
Total People Bought 0 1 5 5
Total Buy Transactions 0 1 7 8
Total Shares Sold 0 0 582,095 677,095
Total Sell Value $0 $0 $465,624 $813,892
Total People Sold 0 0 2 3
Total Sell Transactions 0 0 7 16
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 59
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Alam Kamran CHIEF FINANCIAL OFFICER   •       –      –    2024-02-02 4 D $1.51 $1,945 D/D (1,288) 840,937     -
   Alam Kamran Chief Financial Officer   •       –      –    2024-01-02 4 A $0.00 $0 D/D 590,413 842,225     -
   Nolan Sean P. Chief Executive Officer   •       •      –    2024-01-02 4 A $0.00 $0 D/D 1,184,688 1,185,858     -
   Nagendran Sukumar President and Head of R&D   •       •      –    2024-01-02 4 A $0.00 $0 D/D 863,617 897,843     -
   Manning Paul B 10% Owner   –       –       •   2023-11-17 4 B $1.63 $163,000 I/I 100,000 16,566,667 1.5     -
   Alam Kamran Chief Financial Officer   •       –      –    2023-08-24 4 AS $2.33 $76,890 D/D (33,000) 258,042     -
   Manning Paul B 10% Owner   –       –       •   2023-08-16 4 B $0.90 $14,820,000 I/I 16,466,667 16,466,667 1.5     -
   Nolan Sean P. Chief Executive Officer   •       •      –    2023-08-16 4 B $0.90 $400,000 I/I 444,444 1,535,545 2.66     -
   Stalfort Sean Director   –       •      –    2023-08-16 4 GA $0.00 $0 D/D 50,000 1,049,381     -
   Stalfort Sean Director   –       •      –    2023-08-16 4 B $0.90 $350,000 D/D 388,889 999,381 2.39     -
   Stalfort Sean Director   –       •      –    2023-08-16 4 B $0.90 $350,000 I/I 388,889 884,290 2.1     -
   Donenberg Philip B Director   –       •      –    2023-08-16 4 B $0.90 $100,000 D/D 111,111 114,111 2.39     -
   Session R.a. Ii   –       –       •   2023-07-13 4 S $0.70 $3,741 D/D (5,344) 8,871,747     -
   Session R.a. Ii   –       –       •   2023-07-12 4 S $0.71 $57,030 D/D (80,528) 8,877,091     -
   Session R.a. Ii 10% Owner   –       –       •   2023-06-23 4 S $0.70 $12,735 D/D (18,100) 8,957,619     -
   Stalfort Sean Director   –       •      –    2023-06-22 3 IO $0.00 $0 I/I 0 495,401     -
   Stalfort Sean Director   –       •      –    2023-06-22 3 IO $0.00 $0 D/D 0 610,492     -
   Session R.a. Ii 10% Owner   –       –       •   2023-06-22 4 S $0.70 $7,384 D/D (10,508) 8,975,719     -
   Session R.a. Ii 10% Owner   –       –       •   2023-06-21 4 S $0.70 $97,635 D/D (138,962) 8,986,227     -
   Session R.a. Ii 10% Owner   –       –       •   2023-06-20 4 S $0.71 $210,209 D/D (295,653) 9,125,189     -
   Alam Kamran Chief Financial Officer   •       –      –    2023-05-31 4 A $0.00 $0 D/D 6,230 291,042     -
   Nagendran Sukumar President and Head of R&D   •       •      –    2023-05-16 4 B $0.68 $3,400 D/D 5,000 34,226 2.73     -
   Session R.a. Ii 10% Owner   –       –       •   2023-03-06 4 A $0.00 $0 D/D 251,296 9,420,842     -
   Alam Kamran Chief Financial Officer   •       –      –    2023-02-02 4 A $0.00 $0 D/D 18,691 284,812     -
   Manning Paul B Director   –       •       •   2022-10-31 4 B $2.00 $3,000,000 D/D 1,500,000 1,642,202 3.92     -
  59 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us